BioMAdvanced Diagnostics (private company)
See something wrong or missing? Let us know
Offices:Nantes
Business model:B2B
BioMAdvanced Diagnostics is a French startup spin-off of CR2TI (Centre de Recherche Translationnelle en Transplantation et Immunologie, Université de Nantes) and Nantes University Hospital, working on the identification of biomarkers to assess, predict and diagnose the risk of transplant rejection.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 3.2M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to BioMAdvanced Diagnostics
Name | Criteria | |
---|---|---|
![]() |
Bionomous
60%
|
|
![]() |
iLoF
60%
|
|
![]() |
Naru Intelligence
60%
|
|
![]() |
Novai
60%
|
|
![]() |
Molecule.one
60%
|
|
![]() |
Clustermarket
60%
|
|
![]() |
Nanoligent
60%
|
|
![]() |
OxDX
60%
|
|
![]() |
Exogene
60%
|
|
![]() |
CardiaTec Biosciences
60%
|
|